Search company, investor...
Ludocare company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Seed VC | Alive

Total Raised


Last Raised

$4.3M | 3 mos ago

About Ludocare

Ludocare is developing play or gaming-based solutions specifically designed to meet the needs of patients with chronic diseases and their families. So far they have introduced Joe, a connected companion robot that helps children with asthma, and Leo, for children with cystic fibrosis. The idea is that the robot reminds the children when and how to take their medication, and motivates them by triggering rewards. Ludocare was founded in 2016 and is based in Lyon, France.

Ludocare Headquarters Location

36 quai Fulchiron

Lyon, 69005,


+33 6 98 31 19 26

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ludocare

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ludocare is included in 3 Expert Collections, including Medical Devices.


Medical Devices

8,493 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



1,974 items

This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.


Health IT

7,901 items

Latest Ludocare News

Lyon-based Ludocare tucks in €4.2 million to boost asthma care in kids

Jul 4, 2022

Lyon-based Ludocare tucks in €4.2 million to boost asthma care in kids Insights creates insight and guides strategies with its comprehensive content and reports. Browse popular Insights content. Lyon-based Ludocare tucks in €4.2 million to boost asthma care in kids Ludocare’s robot rings and calls the child and shows the right gestures to take medication through animations on the screen Over 10.7% of children suffer from asthma in France, which represents a major public health issue with compliance estimated at barely 30% due to the cumbersome nature of the treatments and the complexity of the proper use of devices. This low compliance has considerable medical and economic consequences. The overall cost of poor compliance with chronic diseases reaches nearly €9.4 billion in France. Enter French player in the digital therapy market, Ludocare , which has brought in €4.2 million to address the non-compliance issue. The round was backed by Karista and Bpifrance , which is participating via its Patient Autonome fund and the French Tech Seed fund. The funding will facilitate the launch of its clinical study and the implementation of a medical prescription strategy. Founded in 2017 in Lyon, the French player has developed a connected medical companion dedicated to very young children suffering from asthma. Ludocare’s robot rings and calls the child and accompanies the child step by step by stating the name of the medicines and their dosage as well as showing the right gestures to make through animations on the screen. It motivates the child by unlocking daily multimedia rewards. The robot also transmits data on treatments taken to parents via the connected application, data that can be shared with doctors during consultations. The company claims the empowerment of young patients from an early age maximises their chances of optimal care and serene life in better health despite the pathology. Alexandra de la Fontaine , Ludocare’s president and founder said: “We contribute to the improvement of the physical and psychological health of children and the expected mental relief of their families. This fundraising will allow us to demonstrate the clinical and economic benefits of our digital therapy.” Catherine Boule , GM of Karista added: “The first results obtained from the robot deployed in over 200 families are very encouraging and show a drastic improvement in compliance over time. These results must now be validated clinically. Ludocare's strength also lies in its platform, which can be adapted to several chronic diseases.” Joséphine Marie , an investor at Bpifrance, added: “We were attracted by Ludocare's unique positioning, which addresses a major public health and social problem - the lack of compliance among children suffering from chronic diseases, starting with asthma, the leading chronic pediatric disease whose management can be significantly improved. The potential to create a platform that is extended to other diseases and other countries seems to us to create value over time.”

Ludocare Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Ludocare Rank

  • When was Ludocare founded?

    Ludocare was founded in 2016.

  • Where is Ludocare's headquarters?

    Ludocare's headquarters is located at 36 quai Fulchiron, Lyon.

  • What is Ludocare's latest funding round?

    Ludocare's latest funding round is Seed VC.

  • How much did Ludocare raise?

    Ludocare raised a total of $4.3M.

  • Who are the investors of Ludocare?

    Investors of Ludocare include Karista, Bpifrance and La Poste IoT Program.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.